TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy

Journal of Endocrinological Investigation

Volumn 38, Issue 5, 2015, Pages 555-561

  Bufalo, N E ^a   Dos Santos, R B ^b   Marcello, M A ^a   Piai, R P ^a   Secolin, R ^a   Romaldini, J H ^b,c   Ward, L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

^c HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

Author keywords

Autoimmunity; Graves' disease; Polymorphisms; Thyroid stimulating hormone receptor

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAZILIAN; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; FEMALE; FREE THYROXINE INDEX; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; VISUAL ACUITY; BRAZIL; DISEASE COURSE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; INTRON; MIDDLE AGED;

ADULT; BRAZIL; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; INTRONS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, THYROTROPIN;

EID: 84928671771     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0228-9     Document Type: Article

References (52)

1. Weetman AP (2000) Graves' disease. N Engl J Med 343(17):1236-1248. doi: 10.1056/NEJM200010263431707
2. Bartalena L, Fatourechi V (2014) Extrathyroidal manifestations of Graves' disease: a 2014 update. J Endocrinol Invest 37(8):691-700. doi: 10.1007/s40618-014-0097-2
3. Piantanida E, Tanda ML, Lai A, Sassi L, Bartalena L (2013) Prevalence and natural history of Graves' orbitopathy in the XXI century. J Endocrinol Invest 36(6):444-449. doi: 10.3275/8937
4. Yin X, Latif R, Bahn R, Davies TF (2012) Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy. Thyroid 22(7):730-736. doi: 10.1089/thy.2012.0007
5. Ban Y, Tomer Y (2003) The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases. Autoimmunity 36(6-7):367-379
6. Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, Wang PW, Bednarczuk T, Chistiakova EI, Chojm M, Heward JM, Hiratani H, Juo SH, Karabon L, Katayama S, Kurihara S, Liu RT, Miyake I, Omrani GH, Pawlak E, Taniyama M, Tozaki T, Ioannidis JP (2007) Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab 92(8):3162-3170. doi: 10.1210/jc.2007-0147
7. Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S, Meng X, Dong B, Xie G, Qiu F, Hao Z, McCulloch CA, Keystone EC, Peterson AC, Siminovitch KA (2011) The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 43(9):902-907. doi: 10.1038/ng.904
8. Tomer Y, Concepcion E, Greenberg DA (2002) A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12(12):1129-1135. doi: 10.1089/105072502321085234
9. Chistiakov DA, Chistiakova EI, Voronova NV, Turakulov RI, Savost'anov KV (2011) A variant of the Il2ra/Cd25 gene predisposing to graves' disease is associated with increased levels of soluble interleukin-2 receptor. Scand J Immunol 74(5):496-501. doi: 10.1111/j.1365-3083.2011.02608.x
10. Zhang J, Xiao WX, Zhu YF, Muhali FS, Xiao L, Jiang WJ, Shi XH, Zhou LH, Zhang JA (2013) Polymorphisms of interleukin-21 and interleukin-21-receptor genes confer risk for autoimmune thyroid diseases. BMC Endocr Disord 13:26. doi: 10.1186/1472-6823-13-26
11. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF (2002) Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab 87(1):404-407
12. Davies TF, Yin X, Latif R (2010) The genetics of the thyroid stimulating hormone receptor: history and relevance. Thyroid 20(7):727-736. doi: 10.1089/thy.2010.1638
13. Allahabadia A, Heward JM, Nithiyananthan R, Gibson SM, Reuser TT, Dodson PM, Franklyn JA, Gough SC (2001) MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet 358(9286):984-985 [pii]:S0140673601061256
14. Davies TF, Ando T, Lin RY, Tomer Y, Latif R (2005) Thyrotropin receptor-associated diseases: from adenomata to Graves disease. J Clin Invest 115(8):1972-1983. doi: 10.1172/JCI26031
15. Bahn RS (2010) Graves' ophthalmopathy. N Engl J Med 362(8):726-738. doi: 10.1056/NEJMra0905750
16. Ploski R, Brand OJ, Jurecka-Lubieniecka B, Franaszczyk M, Kula D, Krajewski P, Karamat MA, Simmonds MJ, Franklyn JA, Gough SC, Jarzab B, Bednarczuk T (2010) Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. PLoS One 5(11):e15512. doi: 10.1371/journal.pone.0015512
17. Allahabadia A, Heward JM, Mijovic C, Carr-Smith J, Daykin J, Cockram C, Barnett AH, Sheppard MC, Franklyn JA, Gough SC (1998) Lack of association between polymorphism of the thyrotropin receptor gene and Graves' disease in United Kingdom and Hong Kong Chinese patients: case control and family-based studies. Thyroid 8(9):777-780
18. Ban Y, Greenberg DA, Concepcion ES, Tomer Y (2002) A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 12(12):1079-1083. doi: 10.1089/105072502321085171
19. Chistiakov DA, Savost'anov KV, Turakulov RI, Petunina N, Balabolkin MI, Nosikov VV (2002) Further studies of genetic susceptibility to Graves' disease in a Russian population. Med Sci Monit 8(3):CR180-CR184 [pii]:2484
20. Chistyakov DA, Savost'anov KV, Turakulov RI, Petunina NA, Trukhina LV, Kudinova AV, Balabolkin MI, Nosikov VV (2000) Complex association analysis of graves disease using a set of polymorphic markers. Mol Genet Metab 70(3):214-218. doi: 10.1006/mgme.2000.3007
21. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB, Morris JC (1999) Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J Clin Endocrinol Metab 84(9):3328-3335. doi: 10.1210/jcem.84.9.5966
22. Ho SC, Goh SS, Khoo DH (2003) Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins. Thyroid 13(6):523-528. doi: 10.1089/105072503322238773
23. Kaczur V, Takacs M, Szalai C, Falus A, Nagy Z, Berencsi G, Balazs C (2000) Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease. Eur J Immunogenet 27(1):17-23 [pii]:eji187
24. Muhlberg T, Herrmann K, Joba W, Kirchberger M, Heberling HJ, Heufelder AE (2000) Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population. J Clin Endocrinol Metab 85(8):2640-2643
25. Simanainen J, Kinch A, Westermark K, Winsa B, Bengtsson M, Schuppert F, Westermark B, Heldin NE (1999) Analysis of mutations in exon 1 of the human thyrotropin receptor gene: high frequency of the D36H and P52T polymorphic variants. Thyroid 9(1):7-11
26. Khalilzadeh O, Noshad S, Rashidi A, Amirzargar A (2011) Graves' ophthalmopathy: a review of immunogenetics. Curr Genomics 12(8):564-575. doi: 10.2174/138920211798120844
27. Silva CRS, Albuquerque PSB, Ervedosa FR, Mota JWS, Figueira A, Sebbenn AM (2011) Understanding the genetic diversity, spatial genetic structure and mating system at the hierarchical levels of fruits and individuals of a continuous Theobroma cacao population from the Brazilian Amazon. Heredity 106(6):973-985. doi: 10.1038/Hdy.2010.145
28. Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, Kysela B, Carr-Smith JD, Brix T, Hunt PJ, Wiersinga WM, Hegedus L, Connell J, Wass JA, Franklyn JA, Weetman AP, Heward JM, Gough SC (2009) Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Hum Mol Genet 18(9):1704-1713. doi: 10.1093/hmg/ddp087
29. Brand OJ, Gough SC (2011) Immunogenetic mechanisms leading to thyroid autoimmunity: recent advances in identifying susceptibility genes and regions. Curr Genomics 12(8):526-541. doi: 10.2174/138920211798120790
30. Colobran R, Armengol Mdel P, Faner R, Gartner M, Tykocinski LO, Lucas A, Ruiz M, Juan M, Kyewski B, Pujol-Borrell R (2011) Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance. Hum Mol Genet 20(17):3415-3423. doi: 10.1093/hmg/ddr247
31. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, Mackay I, Franklyn JA, Connell JM, Wass JA, Wiersinga WM, Hegedus L, Brix T, Robinson BG, Hunt PJ, Weetman AP, Carey AH, Gough SC (2005) Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet 13(11):1223-1230. doi: 10.1038/sj.ejhg.5201485
32. Liu L, Wu HQ, Wang Q, Zhu YF, Zhang W, Guan LJ, Zhang JA (2012) Association between thyroid stimulating hormone receptor gene intron polymorphisms and autoimmune thyroid disease in a Chinese Han population. Endocr J 59(8):717-723 [pii]:DN/JST.JSTAGE/endocrj/EJ12-0024
33. Graves PN, Tomer Y, Davies TF (1992) Cloning and sequencing of a 1.3 KB variant of human thyrotropin receptor mRNA lacking the transmembrane domain. Biochem Biophys Res Commun 187(2):1135-1143 [pii]:0006-291X(92)91315-H
34. Takeshita A, Nagayama Y, Fujiyama K, Yokoyama N, Namba H, Yamashita S, Izumi M, Nagataki S (1992) Molecular cloning and sequencing of an alternatively spliced form of the human thyrotropin receptor transcript. Biochem Biophys Res Commun 188(3):1214-1219 10.1016/0006-291X(92)91360-3
35. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 17(3):456-520. Q707415233782R31 [pii]
36. Maia AL, Scheffel RS, Meyer EL, Mazeto GM, Carvalho GA, Graf H, Vaisman M, Maciel LM, Ramos HE, Tincani AJ, Andrada NC, Ward LS (2013) The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism. Arq Bras Endocrinol Metabol 57(3):205-232 [pii]:S0004-27302013000300006
37. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L (1997) Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 47(1):9-14
38. Werner SC (1977) Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44(1):203-204
39. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265. doi: 10.1093/bioinformatics/bth457
40. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G∗Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175-191
41. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C, Heufelder AE (1998) Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. J Clin Endocrinol Metab 83(3):998-1002
42. Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ (2011) Clinical relevance of thyroid-stimulating immunoglobulins in graves' ophthalmopathy. Ophthalmology 118(11):2279-2285. doi: 10.1016/j.ophtha.2011.03.030
43. Brix TH, Kyvik KO, Christensen K, Hegedus L (2001) Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86(2):930-934
44. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, Xue C, Marinov GK, Khatun J, Williams BA, Zaleski C, Rozowsky J, Roder M, Kokocinski F, Abdelhamid RF, Alioto T, Antoshechkin I, Baer MT, Bar NS, Batut P, Bell K, Bell I, Chakrabortty S, Chen X, Chrast J, Curado J, Derrien T, Drenkow J, Dumais E, Dumais J, Duttagupta R, Falconnet E, Fastuca M, Fejes-Toth K, Ferreira P, Foissac S, Fullwood MJ, Gao H, Gonzalez D, Gordon A, Gunawardena H, Howald C, Jha S, Johnson R, Kapranov P, King B, Kingswood C, Luo OJ, Park E, Persaud K, Preall JB, Ribeca P, Risk B, Robyr D, Sammeth M, Schaffer L, See LH, Shahab A, Skancke J, Suzuki AM, Takahashi H, Tilgner H, Trout D, Walters N, Wang H, Wrobel J, Yu Y, Ruan X, Hayashizaki Y, Harrow J, Gerstein M, Hubbard T, Reymond A, Antonarakis SE, Hannon G, Giddings MC, Ruan Y, Wold B, Carninci P, Guigo R, Gingeras TR (2012) Landscape of transcription in human cells. Nature 489(7414):101-108. doi: 10.1038/nature11233
45. Pei B, Sisu C, Frankish A, Howald C, Habegger L, Mu XJ, Harte R, Balasubramanian S, Tanzer A, Diekhans M, Reymond A, Hubbard TJ, Harrow J, Gerstein MB (2012) The GENCODE pseudogene resource. Genome Biol 13(9):R51. doi: 10.1186/gb-2012-13-9-r51
46. Wiersinga WM (2011) Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metab 96(8):2386-2394. doi: 10.1210/jc.2011-0307
47. Liu L, Wu HQ, Wang Q, Zhu YF, Zhang W, Guan LJ, Zhang JA (2012) Association between thyroid stimulating hormone receptor gene intron polymorphisms and autoimmune thyroid disease in a Chinese Han population. Endocr J 59(8):717-723
48. Ploski R, Szymanski K, Bednarczuk T (2011) The Genetic Basis of Graves' Disease. Curr Genomics 12(8):542-563
49. Jurecka-Lubieniecka B, Ploski R, Kula D, Szymanski K, Bednarczuk T, Ambroziak U, Hasse-Lazar K, Hyla-Klekot L, Tukiendorf A, Kolosza Z, Jarzab B (2014) Association between polymorphisms in the TSHR gene and Graves' orbitopathy. PLoS One 9(7):e102653. doi: 10.1371/journal.pone.0102653
50. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, Iwatani Y, Akamizu T (2005) Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab 90(5):2898-2903. doi: 10.1210/jc.2004-2148
51. Khalilzadeh O, Anvari M, Esteghamati A, Momen-Heravi F, Rashidi A, Amiri HM, Tahvildari M, Mahmoudi M, Amirzargar A (2010) Genetic susceptibility to Graves' ophthalmopathy: the role of polymorphisms in anti-inflammatory cytokine genes. Ophthalmic Genet 31(4):215-220. doi: 10.3109/13816810.2010.515648
52. Lacka K, Paradowska A, Gasinska T, Soszynska J, Wichary H, Kramer L, Lacki JK (2009) Interleukin-1beta gene (IL-1beta) polymorphisms (SNP -511 and SNP +3953) in thyroid-associated ophthalmopathy (TAO) among the Polish population. Curr Eye Res 34(3):215-220. doi: 10.1080/02713680802699390